REG - Melrose Industries - Directorate Change

Melrose IndustriesAnnouncement

21/06/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230621:nRSU2972Da&default-theme=true

RNS Number : 2972D  Melrose Industries PLC  21 June 2023

 

 

 

 

 

 

21 June 2023

 

Melrose Industries PLC

 

Appointment of Independent Non-Executive Director

 

 

Melrose Industries plc ("Melrose") is pleased to announce the appointment of
Gillian Elcock to its Board as a Non-executive Director with effect from
Wednesday 21 June 2023.

 

Gillian has extensive investment research experience including several years
covering aerospace and defence as an analyst at Putnam Investments and Insight
Investment. Gillian is also the founder and former Managing Director of Denny
Ellison, an independent investment research and training company. She has two
engineering degrees from MIT and an MBA from the Harvard Business School, and
is currently a Non-executive Director of International Biotechnology Trust
plc, and a member of the Board of the CFA UK.

 

Justin Dowley, Non-executive Chairman of Melrose, said:

 

"We are delighted to welcome Gillian to the Board. We look forward to
benefitting from her broad experience and believe she will make a significant
contribution to Melrose as we work to deliver further value for all our
stakeholders."

 

There is no additional information required to be disclosed pursuant to
Listing Rule 9.6.13 in relation to the appointment.

 

 

Enquiries:

 Montfort Communications:        +44 (0) 20 3514 0897

 Nick Miles, Charlotte McMullen  +44 (0) 7739 701634 / +44 (0) 7921 881 800

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAGCGDLGGDDGXG